Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription drug plans for Ozempic, which contains the same active ingredient as Wegovy (semaglutide) but is approved only for diabetes
It is not alarming, but doesnt show what happens over long follow-ups
Does the company explain how the supplement supports GLP-1 (e.g., through berberine, inulin, or bitter melon)
Unlike dietary interventions alone, which often result in weight regain, GLP-1 therapy can help maintain weight loss as long as treatment continues
Key takeaway: Nausea is the most common side effect when starting GLP-1 medications, but it is typically temporary and manageable